AWM
GILD icon

Angeles Wealth Management’s Gilead Sciences GILD Stock Holding History

Angeles Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$827K Buy
5,936
+1,744
+42% +$244K 0.05% 164
2025
Q4 		$515K Buy
4,192
+353
+9% +$42.9K 0.03% 205
2025
Q3 		$426K Sell
3,839
-115
-3% -$13.1K 0.03% 202
2025
Q2 		$438K Buy
3,954
+1,617
+69% +$172K 0.03% 197
2025
Q1 		$262K Buy
2,337
+169
+8% +$17.4K 0.02% 246
2024
Q4 		$200K Buy
+2,168
New +$195K 0.02% 294

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Angeles Wealth Management's GILD Position: Q1 2026 in Review

Angeles Wealth Management increased its Gilead Sciences (GILD) stake by 42% in Q1 2026, buying an estimated $244K and bringing the position to 5,936 shares worth $827K. The position accounts for 0.05% of the portfolio, ranked #164.

Angeles Wealth Management first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Angeles Wealth Management held 5,936 shares of Gilead Sciences worth $827K as of Q1 2026.
  • Angeles Wealth Management bought 1,744 Gilead Sciences shares in Q1 2026, an estimated $244K.
  • Gilead Sciences made up 0.05% of Angeles Wealth Management's portfolio in Q1 2026, its #164 holding.
  • Angeles Wealth Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Angeles Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.